IDEX Biometrics ASA: Registration of share capital increase
Summary by AI BETAClose X
Reference is made to the announcements by IDEX Biometrics ASA (the "Company") on 29 April 2026, regarding a private placement of 9,696,969 shares at NOK 8.25 per share in two tranches, where the second tranche of 3,295,773 shares was resolved issued by the Company's board of directors on 7 May 2026 pursuant to the existing board authorization granted by the Company's extraordinary general meeting on 27 March 2026 ("Tranche 2").
The share capital increases pertaining to Tranche 2 has duly been registered in the Norwegian Register of Business Enterprises. Following the share capital increases, the Company's share capital is NOK 74,808,932 divided into 74,808,932 shares, each with a nominal value of NOK 1 and each carrying one vote at the Company's general meeting.
Listing of the new shares pertaining to Tranche 2 requires approval and publication of a listing prospectus as approved by the Norwegian Financial Supervisory Authority. The shares pertaining to Tranche 2 have been issued on a separate, unlisted ISIN and will only become tradable on Euronext Oslo Børs following approval and publication of the prospectus, expected during Q2 2026.
For more information, please contact:
Anders Storbråten, CEO and CFO
Tel: +47 416 38 582
E-mail: ir@idexbiometrics.com
ABOUT IDEX BIOMETRICS ASA
IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market.
The disclosures set out in this announcement are subject to the disclosure requirement pursuant to section 5-12 of the Norwegian Securities Trading Act.
Latest directors dealings
- 5 hours ago Luceco
- 5 hours ago Helios Towers
- 6 hours ago Wise Class A
- 6 hours ago EDX Medical Group Plc
- 6 hours ago Naked Wines